Capstone Investment Advisors »

Verve Therapeutics shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $142k 10k 13.94
2021-06-30 $301k 5.0k 60.20

More positions owned by Capstone Investment Advisors

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Meta Platforms Cl A Put Option (META)
Amazon Call Option (AMZN)
Apple Put Option (AAPL)
Tesla Motors Put Option (TSLA)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Select Sector Spdr Tr Financial Call Option (XLF)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Broadcom (AVGO)

View all positions for Capstone Investment Advisors

Top funds holding Verve Therapeutics

Alphabet
ARK Investment Management
Vanguard Group
Federated Investors
Casdin Capital
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Jpmorgan Chase & Co
Arch Venture Corp
Redmile Group
Baker Bros. Advisors
EcoR1 Capital
BVF
Palo Alto Investors
Citadel Advisors

View all funds holding Verve Therapeutics